What are Silicon Laboratories's total assets?

Silicon Laboratories (SLAB) holds $1.3B in total assets, up 3.0% year over year.

How much cash does Silicon Laboratories have?

Silicon Laboratories holds $383.1M in cash and equivalents.

Can Silicon Laboratories cover its short-term obligations?

Its current ratio is 5.11 — current assets exceed current liabilities.

Where does Silicon Laboratories's balance sheet data come from?

Every line is extracted from Silicon Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Silicon Laboratories SLAB Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$383.09M+5.2%	$364.22M+6.7%	$341.4M+8.6%	$314.46M-3.2%	$324.88M+15.4%
Short-term investments	$55.77M-29.8%	$79.4M-18.7%	$97.62M-3.4%	$101.08M+1.2%	$99.93M-0.6%
Accounts receivable, net	$77.12M+19.5%	$64.51M-4.2%	$67.31M+19.1%	$56.5M+8.5%	$52.07M-4.4%
Inventories	$103.23M+8.0%	$95.57M+16.3%	$82.19M+1.6%	$80.87M-3.0%	$83.4M-21.1%
Work in process	$85.39M+10.2%	$77.46M+14.3%	$67.8M+4.4%	$64.92M+10.0%	$59.02M-29.4%
Finished goods	$17.84M-1.4%	$18.1M+25.8%	$14.39M-9.8%	$15.95M-34.6%	$24.38M+10.4%
Prepaid expenses and other current assets	$57.11M-18.8%	$70.32M+9.8%	$64.04M-1.2%	$64.84M+11.0%	$58.4M-2.3%
Trading assets	——	——	——	——	——
Total current assets	$676.32M+0.3%	$674.02M+3.3%	$652.56M+5.6%	$617.75M-0.1%	$618.67M+2.8%
Property and equipment, net	$131.82M+2.5%	$128.64M+0.2%	$128.32M-2.3%	$131.28M+1.2%	$129.71M-1.8%
Goodwill	$376.39M0.0%	$376.39M0.0%	$376.39M0.0%	$376.39M0.0%	$376.39M0.0%
Intangible assets, net	$20.84M-9.9%	$23.13M-9.0%	$25.43M-8.3%	$27.72M-10.8%	$31.06M-14.9%
Other non-current assets	$61.09M-9.0%	$67.14M-4.6%	$70.37M+3.6%	$67.93M-7.8%	$73.67M-2.6%
Available-for-sale securities	——	——	——	——	——
Total assets	$1.27B-0.2%	$1.27B+1.3%	$1.25B+2.6%	$1.22B-0.7%	$1.23B+0.6%
Accounts payable	$56.38M+11.2%	$50.72M-8.9%	$55.65M-4.3%	$58.16M+8.1%	$53.82M+26.8%
Accrued expenses	$66.27M-24.4%	$87.71M+8.0%	$81.22M+38.5%	$58.66M-1.3%	$59.42M+13.5%
Operating lease liabilities, current	——	——	——	——	——
Total current liabilities	$132.48M-7.9%	$143.79M-1.0%	$145.31M+20.4%	$120.67M+0.8%	$119.72M+22.3%
Other non-current liabilities	$35.45M+13.9%	$31.11M-16.0%	$37.04M-5.8%	$39.31M-4.9%	$41.36M-7.6%
Total liabilities	$167.93M-4.0%	$174.9M-4.1%	$182.35M+14.0%	$159.99M-0.7%	$161.08M+12.9%
Preferred stock	$0—	$0—	$0—	$0—	$0—
Common stock	250M0.0%	250M0.0%	250M0.0%	250M0.0%	250M+8,333,233%
Additional paid-in capital	$177.55M+12.8%	$157.4M+20.2%	$130.98M+17.4%	$111.56M+15.2%	$96.84M+23.8%
Retained earnings	$920.92M-1.7%	$936.81M-0.3%	$939.5M-1.0%	$949.43M-2.2%	$971.25M-3.0%
Accumulated other comprehensive income (loss)	$63K-68.3%	$199K-14.6%	$233K+188%	$81K-75.2%	$327K+367%
Total stockholders' equity	$1.1B+0.4%	$1.09B+2.2%	$1.07B+0.9%	$1.06B-0.7%	$1.07B-1.1%
Total liabilities and stockholders' equity	$1.27B-0.2%	$1.27B+1.3%	$1.25B+2.6%	$1.22B-0.7%	$1.23B+0.6%
Available-for-Sale Debt Securities - Amortized Cost	——	——	——	——	——
Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)	——	——	——	——	——
Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months)	——	——	$2.28M+684%	$291K-68.9%	$935K-77.7%
AFS and Trading Securities - Unrealized Loss Position (>=12 Months)	——	——	$2.28M+684%	$291K-68.9%	$935K-77.7%
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	——	——	$3.02M-91.5%	$35.46M+331%	$8.24M-68.7%
Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months)	——	——	$3.02M-91.5%	$35.46M+331%	$8.24M-68.7%
Available-for-Sale Debt Securities - Unrealized Loss Position	——	——	$2K-93.9%	$33K+200%	$11K-82.8%
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value	——	——	$2.28M+684%	$291K-68.9%	$935K-77.7%
AFS and Trading Securities - Unrealized Loss Position Fair Value	——	——	$5.3M-85.2%	$35.75M+290%	$9.17M-69.9%
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	——	——	$3.02M-91.5%	$35.46M+331%	$8.24M-68.7%
Cash, Cash Equivalents, and Marketable Securities	——	——	$5.3M-85.2%	$35.75M+290%	$9.17M-69.9%
Cash Cash Equivalents And Short Term Investments	$278.39M-4.3%	$290.79M-12.5%	$332.2M-1.2%	$336.37M+2.7%	$327.57M+13.5%
Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years)	——	——	——	——	——
Investments - Amortized Cost Basis	——	——	——	——	——
Other intangible assets—net	$20.84M-9.9%	$23.13M-9.0%	$25.43M-8.3%	$27.72M-10.8%	$31.06M-14.9%
Investments and sundry assets	$61.09M-9.0%	$67.14M-4.6%	$70.37M+3.6%	$67.93M-7.8%	$73.67M-2.6%
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)	$55.77M-29.8%	$79.4M-18.7%	$97.62M-3.4%	$101.08M+1.2%	$99.93M-0.6%
Deferred revenue and returns liability	$9.82M+83.3%	$5.36M-36.6%	$8.45M+119%	$3.86M-40.5%	$6.48M+111%
Other accrued liabilities	$66.27M-24.4%	$87.71M+8.0%	$81.22M+38.5%	$58.66M-1.3%	$59.42M+13.5%
Unrecognized Tax Benefits	——	——	——	——	——
Unrecognized Tax Benefits - Impacting Effective Tax Rate	——	——	——	——	——
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss	——	——	$1K-50.0%	$2K-60.0%	$5K-66.7%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	33M0.0%	33M+0.3%	32.9M+0.1%	32.8M+1.1%	32.5M0.0%
Convertible Preferred Stock Authorized Shares	10M0.0%	10M0.0%	10M0.0%	10M0.0%	10M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—	0—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$3K0.0%	$3K0.0%	$3K0.0%	$3K0.0%	$3K0.0%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—	$0—
Investments - Gross Unrealized Losses	——	——	$5.3M-85.2%	$35.75M+290%	$9.17M-69.9%
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Share-Based Payment - Unrecognized Cost of Nonvested Awards	——	——	——	——	——
Unrealized Gains on Investments	$81K-67.9%	$252K-15.4%	$298K+104%	$146K-65.6%	$425K+178%
Unrealized Losses on Investments (Before Tax)	$1K—	$0-100%	$2K-93.9%	$33K+200%	$11K-82.8%
Cumulative Cost Basis	——	——	——	——	——
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	$1K—	$0-100%	$2K-93.9%	$33K+200%	$11K-82.8%
Gross Unrealized Gains	$81K-67.9%	$252K-15.4%	$298K+104%	$146K-65.6%	$425K+178%
Total	——	——	——	——	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five	——	——	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five	——	——	——	——	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One	——	——	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One	——	——	——	——	——
Available for sale investments	$55.77M-29.8%	$79.4M-18.7%	$97.62M-3.4%	$101.08M+1.2%	$99.93M-0.6%
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$250M0.0%	$250M0.0%	$250M0.0%	$250M0.0%	$250M0.0%
Common stock, shares issued (in shares)	$32.97M0.0%	$32.96M+0.3%	$32.85M+0.1%	$32.82M+1.1%	$32.47M0.0%
Common Stock, Shares, Outstanding	$32.97M0.0%	$32.96M+0.3%	$32.85M+0.1%	$32.82M+1.1%	$32.47M0.0%
Debt Securities, Available-for-Sale And Cash Equivalents, Fair Value	$278.47M-4.3%	$291.05M-12.5%	$332.5M-1.2%	$336.49M+2.6%	$327.98M+13.6%
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	——	——	$1K-50.0%	$2K-60.0%	$5K-66.7%
Less than 12 months	——	——	$3.02M-91.5%	$35.46M+331%	$8.24M-68.7%
12 months or more	——	——	$2.28M+684%	$291K-68.9%	$935K-77.7%
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	——	——	$1K-96.8%	$31K+417%	$6K-87.8%
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss	——	——	$2K-93.9%	$33K+200%	$11K-82.8%
Debt Securities, Available-for-Sale, Unrealized Loss Position	——	——	$5.3M-85.2%	$35.75M+290%	$9.17M-69.9%
Unrecognized compensation cost related to non-vested awards	——	——	——	——	——
Cash and cash equivalents used in net leverage ratio	——	——	——	——	——
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—	$0—
Short-term investments	——	——	——	——	——
Unrecognized tax benefits	——	——	——	——	——
Amount that if recognized, would affect the effective tax rate or regulatory liability	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Silicon Laboratories.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Silicon Laboratories's total assets?: Silicon Laboratories (SLAB) holds $1.3B in total assets, up 3.0% year over year.
How much cash does Silicon Laboratories have?: Silicon Laboratories holds $383.1M in cash and equivalents.
Can Silicon Laboratories cover its short-term obligations?: Its current ratio is 5.11 — current assets exceed current liabilities.
Where does Silicon Laboratories's balance sheet data come from?: Every line is extracted from Silicon Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.